Scott Salomone, MD

Dr. Scott Salomone, MD (he/him) completed his Psychiatric Residency training with distinction in Spanish Language and Healthcare Disparities at the University of Arizona in Tucson, Arizona where he was additionally the Chief Resident of outpatient psychiatry. He achieved his medical degree with distinction in Medical Education at Saint Louis University in Missouri where he also completed his undergraduate training in neuroscience and international studies. During his training, he gained experience treating a broad variety of mental health conditions in multiple care settings including outpatient medication management and therapy, inpatient hospitalization, consult and liaison for the hospital and emergency department, acute stabilization units, detox and rehabilitation services, and specialized treatment centers. Dr. Salomone has found joy in the meaningful connections built in outpatient practice whether providing medication management, therapeutic services, or both with his patients. With a foundation of medical training, he strives to understand the complex physiology underlying mental health disorders and the medications, therapies, and other modalities used to treat them. He has an appreciation for ways that the mind and the body work in unison in both positive and sometimes self-defeating ways. He has had supervised training in psychodynamic psychotherapy, cognitive behavioral therapy, CBT for Insomnia, dialectical behavioral therapy, emotion focused therapy, and mentalization based therapy. Additionally, he has completed Level 1 and Level 2 training of the Gottman Method for couple’s therapy. Dr. Salomone is passionate about care for the underserved and reducing stigma around mental health. He provides psychiatric services in both English and Spanish. He understands there are many factors that influence one’s ability and willingness to seek help and hopes to create a welcoming space for all to come and explore their mental health. As an advocate for the LGBTQ community, he is dedicated to providing evidence-based, individualized, and compassionate care to patients of all identities. He is excited to take part in researching the potential benefits of psychedelic medicines for mental health and utilizing treatments already available such as ketamine-assisted psychotherapy and esketamine.